95-11-4

Applied Filters:

Keyword:'95-11-4'

Showing 61-90 of 2893 results for "95-11-4" within Technical Documents

Cancer medication in Urine - separation of 4'-Epirubicin hydrochloride - using a LiChrospher RP select B column

LiChroCART® 25-4 LiChrospher® RP-4 ADS HPLC cartridge set, contains 1 LiChroCART® 25-4 LiChrospher® RP-4 ADS 1 manu-CART® 150206 Merck KGaA, 64271 Darmstadt, GERMANY 2008-09-11 Page 4 of 4 http

Cancer medication in Liver tumor - separation of 4'-Epirubicin hydrochloride - using a LiChrospher RP select B column

LiChroCART® 25-4 LiChrospher® RP-4 ADS HPLC cartridge set, contains 1 LiChroCART® 25-4 LiChrospher® RP-4 ADS 1 manu-CART® 150206 Merck KGaA, 64271 Darmstadt, GERMANY 2008-09-11 Page 4 of 4 http

Product Information Sheet - 11814524001

Contact and Support. 6 7 8 9 10 11 12 13 https://www.sigmaaldrich.com 11 21 .0 49 95 68 60 01

Data Sheet - SRP5082

0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼150 kDa Purity: 70–95% (SDS-PAGE, see Figure 1) Specific Activity: 95–129 nmole/min/mg (see Figure 2) Precautions and Disclaimer This product

Bulletin - 11277081001

U/μl 11 008 404 001 500 U, 2 U/μl 11 008 412 001 DIG DNA Labeling Mix 50 μl, 10x conc., 25 standard reactions 11 277 065 910 Deoxynucleoside Triphosphate Set 4 x 100 μl, 4 x 10

Product Information Sheet-11277081001

U/μl 11 008 404 001 500 U, 2 U/μl 11 008 412 001 DIG DNA Labeling Mix 50 μl, 10x conc., 25 standard reactions 11 277 065 910 Deoxynucleoside Triphosphate Set 4 x 100 μl, 4 x 10

Cancer medication in Plasma - separation of 4'-Epirubicin hydrochloride - using a LiChrospher RP select B column

LiChroCART® 25-4 LiChrospher® RP-4 ADS HPLC cartridge set, contains 1 LiChroCART® 25-4 LiChrospher® RP-4 ADS 1 manu-CART® 150206 Merck KGaA, 64271 Darmstadt, GERMANY 2008-09-11 Page 4 of 4 http

Cancer medication in Plasma - separation of Epirubicin, Epirubicinol, 3-Epirubicin aglycon, Epirubicinol aglycon, 7-Deoxyepirubicinol aglycon - using a LiChrospher RP select

LiChroCART® 25-4 LiChrospher® RP-4 ADS HPLC cartridge set, contains 1 LiChroCART® 25-4 LiChrospher® RP-4 ADS 1 manu-CART® 150206 Merck KGaA, 64271 Darmstadt, GERMANY 2008-09-11 Page 4 of 4 http

Data Sheet - SRP5006

Product Information Sheet-11585550910

membrane. 11 636 090 910 Water, PCR Grade 25 ml, 25 x 1 ml 03 315 932 001 25 ml, 1 x 25 ml 03 315 959 001 100 ml, 4 x 25 ml 03 315 843 001 PCR

RECOMBINANT HUMAN LEUKEMIA INHIBITORY FACTOR

cells. Blood 95: 1957-1966. 2288882200 SSiinnggllee OOaakk DDrriivvee •• TTeemmeeccuullaa,,

Proc. Natl. Acad. Sci. USA, 95, 3792 (1998). 11. Lee, F.S., et al., Proc. Natl. Acad. Sci. USA, 95, 9319 (1998). 12. Nakano, H., et al., Proc. Natl. Acad. Sci. USA, 95, 3537 (1998). 13. Takeda

Data Sheet - I9767

Proc. Natl. Acad. Sci. USA, 95, 3792 (1998). 11. Lee, F.S., et al., Proc. Natl. Acad. Sci. USA, 95, 9319 (1998). 12. Nakano, H., et al., Proc. Natl. Acad. Sci. USA, 95,

Biologics 28.1

. Purity: ≥95% by HPLC. Soluble in DMSO. M.W. 301.8. Cat. No. 219448 5 mg Ref.: Clare, P.M., et al. 2001. J. Biol. Chem. 276, 48292. GSK-3 Inhibitor {3-(3-Carboxy-4-chloroanilino)-4-(3- nitrophenyl

Data Sheet - SRP5072

Data Sheet - SRP5216

segregate with spinocerebellar ataxia type 11. Nature Genet., 39, 1434-1436 (2007). PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC. TD,MAM 11/11-1 2011 Sigma-Aldrich Co. LLC. All rights

Data Sheet - SRP5169

Measuring Immune Response and Cytokine Autoantibodies in Human Sepsis Samples

-25,000 1.26 4.00 6.29 97 IL-2 0.64-10,000 0.27 4.02 4.82 95 IL-3 1.28-20,000 0.29 3.26 5.62 100 IL-4 0.64-10,000 0.20 4.55 5.94 95 IL-5 0.64-10,000 0.17 3.99 5.42 99 IL-6 0.64-10,000 0.14

Detergents Properties and Applications

53-8 302-95-4 863-57-0 145-42-6 1180-95-6 137-16-6 2044-56-6 151-21-3 57-09-0 1119-97-7 MW (anhydrous) 431 415 488 538 522 293 272 289 365 337 CMC** (mM) 9-15 2-6 7 3-11 1-4 14.6 7-10 7-10 1 4-5 Aggregation

PCR Protocols and Guides - Simplify your gene discovery

Profile 4 Initial Denaturation 98 °C 30 s 94 °C 2 min 95 °C 2 min 95 °C 2 min 29 cycles 98 °C

Vantage®L BioChromatography Laboratory Columns

resistance (dependent on contact temperature and time) 10 9 8 7 4 3 6 1 3 4 2 9 10 5 7 8 Extension Kit 11 12 1

RiOs™ 30/50/100/150/200

The riOs™ SySTem 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 1

Product Information Sheet-04743750001

Pre-Incubation 92 – 95(1) 2 min 1 Denaturation Annealing Elongation 92 – 95(1) 45 – 65(3) 72(4) 15 sec 30 sec 45 sec – 3 min 30 – 40(2) Final Elongation 72 up

Product Information Sheet-fhifi-ro

Pre-Incubation 95 2 min 1 Denaturation Annealing Elongation 95 55 – 72 72 30 sec 30 sec 30 sec – 3 min(1) 35 Final Elongation 72 4 – 7 min 1 Cooling 4 indefinitely 1

MOUSE ANTI-PROSTATE SPECIFIC ANTIGEN MONOCLONAL ANTIBODY

minute sequential baths of: 70% ethyl alcohol, 80% ethyl alcohol, 90% ethyl alcohol, 95% ethyl alcohol, 95% ethyl alcohol, 100% ethyl alcohol, 100% ethyl alcohol, 50% Xylene/50% ethyl alcohol, Xylene

GOAT ANTI-CHOLINE ACETYLTRANSFERASE (ChAT)

REFERENCES: 1. Brain Research Bulletin (1987) 18:447-455. 2. Sleep (1988) 11:1-16. 3. Neuroscience (1989) 32:685-700. 4. Brain Research (1990) 517:224-228. 5. Brain Research (1990) 532:317-322.

Data Sheet - R5903

. C., Annu. Rev. Neurosci., 21, 75-95 (1998). 3. Stein, M.P., et al., Adv. Drug Deliv. Rev., 55, 1421- 1437 (2003). 4. Pfeffer, S.R., Trends Cell Biol., 11, 487-491 (2001). 5. Peden, A.A., et al.

Page 3 of 97